The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Network‐based Approaches in Pharmacology
Open accessAbstract
In drug discovery, network‐based approaches are expected to spotlight our understanding of drug action across multiple layers of information. On one hand, network pharmacology considers the drug response in the context of a cellular or phenotypic network. On the other hand, a chemical‐based network is a promising alternative for characterizing the chemical space. Both can provide complementary support for the development of rational drug design and better knowledge of the mechanisms underlying the multiple actions of drugs. Recent progress in both concepts is discussed here. In addition, a network‐based approach using drug‐target‐therapy data is introduced as an example.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emergence of Scaling in Random Networks
Barabási, A.-L., & Albert, R. (1999) · Science · doi:10.1126/science.286.5439.509 · Cited by 36,135
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Piñero, J., Bravo, À., Queralt-Rosinach, N., Gutiérrez-Sacristán, A., Deu-Pons, J., Centeno, E., García-García, J., Sanz, F., & Furlong, L. I. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw943 · Cited by 2,680
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,831
Yıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-L., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,708
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Kerkelä, R., Grazette, L., Yacobi, R., Iliescu, C., Patten, R., Beahm, C., Walters, B., Shevtsov, S., Pesant, S., Clubb, F. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1446 · Cited by 1,159
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Large-scale prediction and testing of drug activity on side-effect targets
Lounkine, E., Keiser, M. J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J. L., Lavan, P., Weber, E., Doak, A. K., Côté, S., et al. (2012) · Nature · doi:10.1038/nature11159 · Cited by 881
Global mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811
Multicomponent therapeutics for networked systems
Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769
Targeting the cancer kinome through polypharmacology
Knight, Z. A., Lin, H., & Shokat, K. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2787 · Cited by 674
Wang, Y., Bryant, S. H., Cheng, T., Wang, J., Gindulyte, A., Shoemaker, B. A., Thiessen, P. A., He, S., & Zhang, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1118 · Cited by 671
Network analyses in systems pharmacology
Berger, S. I., & Iyengar, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp465 · Cited by 510
Drug repurposing from an academic perspective
Oprea, T. I., Bauman, J. E., Bologa, C. G., Buranda, T., Chigaev, A., Edwards, B. S., Jarvik, J. W., Gresham, H. D., Haynes, M. K., Hjelle, B., et al. (2011) · Drug Discovery Today: Therapeutic Strategies · doi:10.1016/j.ddstr.2011.10.002 · Cited by 364
Strategies to overcome resistance to targeted protein kinase inhibitors
Daub, H., Specht, K., & Ullrich, A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1579 · Cited by 334
Pharos: collating protein information to shed light on the druggable genome
Nguyen, D.-T., Mathias, S., Bologa, C., Brunak, S., Fernandez, N., Gaulton, A., Hersey, A., Holmes, J., Jensen, L. J., Karlsson, A., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1072 · Cited by 279
Data completeness—the Achilles heel of drug-target networks
Mestres, J., Gregori-Puigjané, E., Valverde, S., & Solé, R. V. (2008) · Nature Biotechnology · doi:10.1038/nbt0908-983 · Cited by 265
Network-based methods for human disease gene prediction
Wang, X., Gulbahce, N., & Yu, H. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr024 · Cited by 243
Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach
Emig, D., Ivliev, A., Pustovalova, O., Lancashire, L., Bureeva, S., Nikolsky, Y., & Bessarabova, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060618 · Cited by 241
PROMISCUOUS: a database for network-based drug-repositioning
von Eichborn, J., Murgueitio, M. S., Dunkel, M., Koerner, S., Bourne, P. E., & Preissner, R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1037 · Cited by 225
In silico methods to address polypharmacology: current status, applications and future perspectives
Lavecchia, A., & Cerchia, C. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.12.007 · Cited by 225
Mestres, J., Gregori-Puigjané, E., Valverde, S., & Solé, R. V. (2009) · Molecular BioSystems · doi:10.1039/b905821b · Cited by 203
MMP-Cliffs: Systematic Identification of Activity Cliffs on the Basis of Matched Molecular Pairs
Hu, X., Hu, Y., Vogt, M., Stumpfe, D., & Bajorath, J. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3001138 · Cited by 203
Human diseases through the lens of network biology
Furlong, L. I. (2013) · Trends in Genetics · doi:10.1016/j.tig.2012.11.004 · Cited by 196
Pendergrass, S. A., Brown-Gentry, K., Dudek, S. M., Torstenson, E. S., Ambite, J. L., Avery, C. L., Buyske, S., Cai, C., Fesinmeyer, M. D., Haiman, C., et al. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20589 · Cited by 175
Analysis of multiple compound–protein interactions reveals novel bioactive molecules
Yabuuchi, H., Niijima, S., Takematsu, H., Ida, T., Hirokawa, T., Hara, T., Ogawa, T., Minowa, Y., Tsujimoto, G., & Okuno, Y. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.5 · Cited by 153
Wawer, M. J., Peltason, L., Weskamp, N., Teckentrup, A., & Bajorath, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800867g · Cited by 150
On the origins of drug polypharmacology
Jalencas, X., & Mestres, J. (2012) · MedChemComm · doi:10.1039/c2md20242e · Cited by 143
ChemProt-3.0: a global chemical biology diseases mapping
Kringelum, J. V., Kjærulff, S. K., Brunak, S., Lund, O., Oprea, T. I., & Taboureau, O. (2016) · Database · doi:10.1093/database/bav123 · Cited by 143
Self-citationIskar, M., Zeller, G., Blattmann, P., Campillos, M., Kuhn, M., Kaminska, K. H., Runz, H., Gavin, A., Pepperkok, R., van Noort, V., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.20 · Cited by 118
ChemProt: a disease chemical biology database
Taboureau, O., Nielsen, S. K., Audouze, K., Weinhold, N., Edsgärd, D., Roque, F. S., Kouskoumvekaki, I. A., Bora, A., Curpan, R. F., Jensen, T. S., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq906 · Cited by 115
Self-citationOprea, T. I., Nielsen, S. K., Ursu, O., Yang, J. J., Taboureau, O., Mathias, S. L., Kouskoumvekaki, I. A., Sklar, L. A., & Bologa, C. (2011) · Molecular Informatics · doi:10.1002/minf.201100023 · Cited by 115
Self-citationChemoproteomic approaches to drug target identification and drug profiling
Bantscheff, M., & Drewes, G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.11.003 · Cited by 110
Identifying Network of Drug Mode of Action by Gene Expression Profiling
Iorio, F., Tagliaferri, R., & di Bernardo, D. (2009) · Journal of Computational Biology · doi:10.1089/cmb.2008.10tt · Cited by 106
Network-Based Approaches in Drug Discovery and Early Development
Harrold, J. M., Ramanathan, M. K., & Mager, D. E. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.176 · Cited by 103
Network Neighbors of Drug Targets Contribute to Drug Side-Effect Similarity
Brouwers, L., Iskar, M., Zeller, G., van Noort, V., & Bork, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022187 · Cited by 101
Human protein interaction networks across tissues and diseases
Yeger‐Lotem, E., & Sharan, R. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00257 · Cited by 94
A global view of drug-therapy interactions
Nacher, J. C., & Schwartz, J. (2008) · BMC Pharmacology · doi:10.1186/1471-2210-8-5 · Cited by 94
Ligand-Based Approach to In Silico Pharmacology: Nuclear Receptor Profiling
Mestres, J., Martín‐Couce, L., Gregori‐Puigjané, E., Cases, M., & Boyer, S. K. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600300k · Cited by 89
Carrella, D., Napolitano, F., Rispoli, R., Miglietta, M. M., Carissimo, A., Cutillo, L., Sirci, F., Gregoretti, F., & di Bernardo, D. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu058 · Cited by 86
Li, Z., Huang, M.-H., Zhong, W., Liu, Z., Xie, Y. X., Dai, Z., & Zou, X. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv695 · Cited by 69
Pharmacological Approaches in the Treatment of Binge Eating Disorder
Appolinário, J. C., & McElroy, S. L. (2004) · Current Drug Targets · doi:10.2174/1389450043490488 · Cited by 63
Network-Based Analysis and Characterization of Adverse Drug–Drug Interactions
Takarabe, M., Shigemizu, D., Kotera, M., Goto, S., & Kanehisa, M. I. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200367w · Cited by 61
IPAD: the Integrated Pathway Analysis Database for Systematic Enrichment Analysis
Zhang, F., & Drabier, R. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-s15-s7 · Cited by 58
Bridging the Gap between Genotype and Phenotype via Network Approaches
Kim, Y.-A., & Przytycka, T. M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00227 · Cited by 55
EXPLORING COMPOUND PROMISCUITY PATTERNS AND MULTI-TARGET ACTIVITY SPACES
Hu, Y., Gupta‐Ostermann, D., & Bajorath, J. (2014) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201401003 · Cited by 52
Barneh, F., Jafari, M., & Mirzaie, M. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv094 · Cited by 50
Psychotropic Drugs in the Treatment of Obesity: What Promise?
Appolinário, J. C., Bueno, J. R., & Coutinho, W. F. (2004) · CNS Drugs · doi:10.2165/00023210-200418100-00002 · Cited by 47
The impact of network biology in pharmacology and toxicology
Panagiotou, G., & Taboureau, O. (2012) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2012.657237 · Cited by 47
Self-citationTaboureau, O., & Jørgensen, F. S. (2011) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620711795508322 · Cited by 46
Self-citationComposition and Topology of Activity Cliff Clusters Formed by Bioactive Compounds
Stumpfe, D., Dimova, D., & Bajorath, J. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400728r · Cited by 39
When pharmaceutical companies publish large datasets: an abundance of riches or fool's gold?
Ekins, S., & Williams, A. J. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.010 · Cited by 38
Providing data science support for systems pharmacology and its implications to drug discovery
Hart, T. D., & Xie, L. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1135126 · Cited by 35
Lessons learned from the design of chemical space networks and opportunities for new applications
Vogt, M., Stumpfe, D., Maggiora, G. M., & Bajorath, J. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9906-3 · Cited by 35
The relationship between rational drug design and drug side effects
Wang, J., Li, Z., Qiu, C., Wang, D., & Cui, Q. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr061 · Cited by 33
Small-World Phenomena in Chemical Library Networks: Application to Fragment-Based Drug Discovery
Tanaka, N., Ohno, K., Niimi, T., Moritomo, A., Mori, K., & Orita, M. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900123v · Cited by 31
Drug combinatorics and side effect estimation on the signed human drug-target network
Torres, N. B., & Altafini, C. (2016) · BMC Systems Biology · doi:10.1186/s12918-016-0326-8 · Cited by 27
Baron, D., Dubois, E., Bihouée, A., Teusan, R., Steenman, M., Jourdon, P., Magot, A., Péréon, Y., Veitia, R. A., Savagner, F., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-113 · Cited by 25
Sibutramine-induced mania as the first manifestation of bipolar disorder
Waszkiewicz, N., Zalewska‐Szajda, B., Szajda, S. D., Simonienko, K., Zalewska, A., Szulc, A., Ładny, J. R., & Zwierz, K. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-43 · Cited by 25
Yilmaz, S., Jonveaux, P., Bicep, C., Pierron, L., Smaïl‐Tabbone, M., & Devignes, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn612 · Cited by 25
The application of sparse estimation of covariance matrix to quadratic discriminant analysis
Sun, J., & Zhao, H. (2015) · BMC Bioinformatics · doi:10.1186/s12859-014-0443-6 · Cited by 24
Zhang, B., Vogt, M., Maggiora, G. M., & Bajorath, J. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9852-5 · Cited by 22
SAR Monitoring of Evolving Compound Data Sets Using Activity Landscapes
Iyer, P., Hu, Y., & Bajorath, J. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100505m · Cited by 20
Chemical biology databases: from aggregation, curation to representation
Audouze, K., & Taboureau, O. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.03.003 · Cited by 4
Self-citation
Cited by
Zhao, L., Zhang, H., Li, N., Chen, J., Xu, H., Wang, Y., & Liang, Q. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116306 · Cited by 963
Network pharmacology: a crucial approach in traditional Chinese medicine research
Zhai, Y., Liu, L., Zhang, F., Chen, X., Wang, H., Zhou, J., Chai, K., Liu, J., Lei, H., Lu, P., et al. (2025) · Chinese Medicine · doi:10.1186/s13020-024-01056-z · Cited by 260
Hot-spot analysis for drug discovery targeting protein-protein interactions
Rosell, M., & Fernández-Recio, J. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1430763 · Cited by 105
Ren, F., Wei, J., Chen, Q., Hu, M., Yu, L., Mi, J., Zhou, X., Qin, D., Wu, J., & Wu, A. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.030 · Cited by 97
Metadata
- Authors
- Boezio, B., Audouze, K., Ducrot, P., & Taboureau, O.
- Venue
- Molecular Informatics
- Publisher
- Wiley
- Published
- 2017-07-10
- Volume
- 36
- Issue
- 10
- ISSN
- 1868-1743 (ISSN-L)
- 1868-1751
- OpenAlex
- W2736172938
- Cited by
- 359
- References
- 68
- FWCI
- 13.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.